Literature DB >> 4370457

The effects of some anti-inflammatory drugs on the acute-phase proteins in rheumatoid arthritis.

B McConkey, R A Crockson, A P Crockson, A R Wilkinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4370457

Source DB:  PubMed          Journal:  Q J Med        ISSN： 0033-5622


× No keyword cloud information.
  48 in total

1.  Inflammatory disease and its control in rheumatic disorders.

Authors:  F D Hart
Journal:  Br Med J       Date:  1975-10-25

2.  Fenclofenac in the treatment of rheumatoid arthritis and ankylosing spondylitis.

Authors:  M S Akyol; M Anderson; M Thompson
Journal:  Proc R Soc Med       Date:  1977

3.  Effect of short-term aspirin use on C-reactive protein.

Authors:  D Feng; R P Tracy; I Lipinska; J Murillo; C McKenna; G H Tofler
Journal:  J Thromb Thrombolysis       Date:  2000-01       Impact factor: 2.300

4.  The new antirheumatic drugs.

Authors:  F D Hart
Journal:  Drugs       Date:  1975       Impact factor: 9.546

5.  Tenidap, a structurally novel drug for the treatment of arthritis: antiinflammatory and analgesic properties.

Authors:  P F Moore; D L Larson; I G Otterness; A Weissman; S B Kadin; F J Sweeney; J D Eskra; A Nagahisa; M Sakakibara; T J Carty
Journal:  Inflamm Res       Date:  1996-02       Impact factor: 4.575

6.  Serum alpha 1 antichymotrypsin concentration as a marker of disease activity in rheumatoid arthritis.

Authors:  M D Chard; J Calvin; C P Price; T E Cawston; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1988-08       Impact factor: 19.103

7.  Rheumatoid inflammation and joint destruction: cause and effect or parallel phenomena?

Authors:  J D Williams; D L Scott; F B DeBrito; D A Willoughby; E C Huskisson
Journal:  Agents Actions       Date:  1986-08

8.  Raised C-reactive protein response in rheumatoid arthritis patients with secondary Sjögren's syndrome.

Authors:  P Youinou; P Fauquert; Y L Pennec; B Bendaoud; P Katsikis; P Le Goff
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

9.  A comparison of serum biochemistry in ankylosing spondylitis, seronegative and seropositive rheumatoid arthritis.

Authors:  J S Dixon; H A Bird; V Wright
Journal:  Ann Rheum Dis       Date:  1981-08       Impact factor: 19.103

10.  C-reactive protein levels in patients with rheumatoid arthritis: the impact of therapy.

Authors:  M Tishler; D Caspi; M Yaron
Journal:  Clin Rheumatol       Date:  1985-09       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.